Cervical cancer test kit

HPV

HPV-DNA is a mandatory screening test for cervical cancer in women regulated by the FDA. Cervical cancer is currently the only cancer with a clear cause. HPV infection with the high-risk HPV is found in 97% of cervical cancer patients. High-risk types of HPV -- especially HPV16 and HPV18 -- cause genital warts, external genital cancer, cervical cancer and high cervical intraepithelial neoplasia. HPV High Risk Detection: HPV16,18,31,33,35,39,45,51,52,56,58,59,68,66 HPV Genotyping: HPV 16, HPV 18 Sample type: Female cervical exfoliated cell Application ● Direct detection of HPV-DNA ● More sensitive, specific, accurate and rapid ● Estimate viral load and cancer risk ● Evaluate HPV vaccine efficacy and prognosis efficacy Compared with the reference reagent, Kindmay High-Risk HPV nucleic acid detection kit: The positive coincidence rate: 92.7%. The negative coincidence rate: 97.9%. The overall coincidence rate: 95.3%.